Novo Nordisk, Emcure to launch weight-loss drug under new brand in India
Novo Nordisk launched Wegovy in India in June, three months after Eli Lilly (LLY.N), opens new tab introduced its competing weight-loss product Mounjaro in the world’s most populous nation.
Wegovy’s 2.4 mg dose is priced at 26,015 rupees for a month’s supply in India, while pricing for Poviztra was not disclosed.
“This partnership is part of Novo Nordisk India’s efforts to ensure its innovative treatments reach a greater number of patients in India,” the Danish company said in an exchange filing.
Last month, Eli Lilly also partnered with Cipla (CIPL.NS), opens new tab to sell its weight-loss drug under a separate brand in India.
